Introduction
The involvement of B cells in the pathogenesis of multiple sclerosis (MS) has been reviewed elsewhere (Antel and Bar-Or, 2006; McFarland, 2008; Owens et al., 2006) and is supported by the therapeutic efficacy of the B cell depleting anti-CD20 drug rituximab in patients with MS (Hauser et al., 2008) . This finding supports the concept that the B cell pool in MS patients harbors a subset that contributes to disease pathology. We hypothesized that if the cellular pool in MS patients is dysregulated, one would expect that antibody genes utilized by B cells circulating within the cerebrospinal fluid (CSF) would display a pattern of somatic hypermutation not found in healthy donors or patients with other neurological diseases. Indeed, our laboratory has recently identified a novel pattern of somatic hypermutation that is unique to MS CSF B cells and not found in control derived sequences (Cameron et al., 2009) . We investigated the utility of this antibody gene signature (AGS) as a molecular genetic tool to identify CIS patients at risk to develop MS that would subsequently convert to definite MS. Application of the AGS tool demonstrated the ability to predict conversion to definite MS with an accuracy of 91% (Cameron et al., 2009 ). The goal of this current study was to determine whether this MS-specific AGS identified in the CSF is also present in the CNS tissue of patients with MS.
Materials and methods

Specimens
CNS tissue was dissected at autopsy from four subjects with clinically definite MS. Specimens were immediately snap-frozen then stored at −80°C. Table 1 summarizes the clinical features of each subject. All human subject research was approved from the local human research internal review boards.
Immunoglobulin variable region cloning
B cell immunoglobulin variable region libraries were assembled from tissue sections prepared on a cryostat. RNA was extracted from tissue sections 14-μm thick using the RNAeasy Mini Kit (Qiagen) according to the manufacturer's instructions. From the total RNA, cDNA was synthesized and human Ig variable region genes were amplified as described previously (Willis et al., 2009) . Journal of Neuroimmunology 226 (2010) 192-193 
